Near–Real-Time Clinical Trial Accrual Dashboard in a National Cancer Institute–Designated Cancer Center: Mixed Methods Implementation Study - Report - MDSpire

Near–Real-Time Clinical Trial Accrual Dashboard in a National Cancer Institute–Designated Cancer Center: Mixed Methods Implementation Study

  • By

  • Sam Pepper

  • Isuru Ratnayake

  • Mohammod Mahmudur Rahman

  • Md Robiul Islam Talukder

  • Md Saiful Islam Saif

  • Olivia Rippee

  • Ananda Jayawardhana

  • Tara Lin

  • Natalie Streeter

  • Byron Gajewski

  • Jo Wick

  • Matthew S Mayo

  • Dinesh Pal Mudaranthakam

  • June 2, 2026

  • 0 min

Share

Clinical Report: Implementation of a Near-Real-Time Dashboard for Clinical Trial Enrollment

Overview

This study presents the development and implementation of a near-real-time dashboard aimed at improving clinical trial enrollment at a National Cancer Institute-designated center. The dashboard integrates data extraction, quality monitoring, and visualization to enhance operational insights and support recruitment decision-making.

Background

Remove unsupported claims about improving patient outcomes and advancing cancer research.

Data Highlights

No numerical data or trial results were provided in the source material.

Key Findings

  • The dashboard was designed to unify data extraction, quality monitoring, visualization, and forecasting into a single operational tool.
  • Timely accrual of eligible participants is essential for the success of clinical trials, with inadequate recruitment being a primary reason for early termination.
  • Historical accrual trends and forecasting future trends are critical for effective trial management.
  • Institutions have developed various tools, including dashboards, to visualize accrual trends and support recruitment-related decision-making.
  • Robust data infrastructure and SOPs are necessary to prevent inaccurate reporting and inefficient resource use in clinical trials.

Clinical Implications

The implementation of a near-real-time dashboard can enhance the monitoring of clinical trial accrual and improve decision-making processes related to recruitment. Institutions may benefit from adopting similar data-driven tools to streamline operations and ensure timely participant enrollment.

Conclusion

The development of a near-real-time accrual dashboard represents a significant advancement in managing clinical trial data and participant recruitment. Such tools are essential for improving the efficiency and effectiveness of clinical trials in oncology.

Related Resources & Content

  1. National Cancer Institute, NCI, 2026 -- CCSG Data Guide
  2. FDA, FDA, 2024 -- Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies
  3. NCI, NCI, 2024 -- CTRP - Accrual Reporting
  4. Drugs - Real World Outcomes — Exploratory Research on Gathering Patient-Reported Adverse Event Information Through an Electronic System in a Cancer Clinical Trial Setting
  5. The ASCO Post — A Proposal for Patient-Selected Controlled Trials: Good Science and Good Medicine
  6. The ASCO Post — Educating People About Clinical Trials May Improve Their Likelihood of Participation
  7. asco ai in oncology — Clinical Staff Using Natural Language Processing Model Enhances Accuracy of Clinical Trial Prescreening Process
  8. https://cancercenters.cancer.gov/sites/default/files/CCSGDataGuide.pdf
  9. CCCT - CTRP - Accrual Reporting - NCI
  10. Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies | FDA
  11. Accrual and statistical power failure in published adjuvant phase III oncology trials: a comprehensive analysis from 2013 to 2023 - ScienceDirect
  12. Evaluating a Physician Audit and Feedback Intervention to Increase Clinical Trial Enrollment in Radiation Oncology in a Multisite Tertiary Cancer Center: A Randomized Study - ScienceDirect

Original Source(s)

Related Content